Underlying Mechanisms of Renal Lipotoxicity in Obesity
Open Access
- 9 January 2019
- journal article
- review article
- Published by S. Karger AG in Nephron
- Vol. 143 (1) , 28-32
Abstract
The recent and ongoing worldwide increase in the prevalence of obesity parallels the increase in the incidence of chronic kidney disease (CKD). This association suggests an implication of lipotoxicity in the development of kidney diseases. The increased influx of lipids into the kidney can be explained in the context of the “Adipose Tissue Expandability Hypothesis”. This hypothesis states that the adipose tissue has a limited expansion capability, which is different for each individual, and once this limit is reached, the adipose tissue cannot store any more lipids and will thus release them into the bloodstream. The accumulation of lipids in the kidney is known as renal lipotoxicity. Renal lipotoxicity is known to cause detrimental effects on the kidney by several mechanisms of action including reclusion of pro-inflammatory factors, oxidative and ER stress development, insulin resistance (IR), lipid metabolism deregulation or renin-angiotensin aldosterone system overactivation. Isoform peroxisome proliferator-activated receptor gamma (PPARγ) seems to play an important role in the development of this lipotoxicity as proven by several studies in animals and cultured cells. Thus, PPARγ agonists are of interest in the therapeutic approach to treat CKD in the context of obesity. This review aims to summarize our current knowledge of the mechanism by which lipotoxicity affects renal structure and function using in vivo and in vitro models as examples focusing on PPARγ.Keywords
This publication has 18 references indexed in Scilit:
- Immunologic and endocrine functions of adipose tissue: implications for kidney diseaseNature Reviews Nephrology, 2017
- Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesisNature Reviews Nephrology, 2016
- Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidneyAmerican Journal of Physiology-Renal Physiology, 2016
- Fatty kidney: emerging role of ectopic lipid in obesity-related renal diseaseThe Lancet Diabetes & Endocrinology, 2014
- Adipokines promote chronic kidney diseaseNephrology Dialysis Transplantation, 2013
- Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney FunctionCell Metabolism, 2010
- Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cellsAmerican Journal of Physiology-Renal Physiology, 2010
- Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspectiveBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte DifferentiationNew England Journal of Medicine, 1998
- The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the RatJournal of Experimental Medicine, 1997